Pfizer Global Research and Development, Groton, CT 06340, USA.
Biomarkers. 2012 Sep;17(6):524-31. doi: 10.3109/1354750X.2012.694476. Epub 2012 Jun 7.
Adult rats were treated acutely with peripheral kainic acid (KA), and changes in brain-derived neurotrophic factor (BDNF) mRNA and protein were tracked over time across multiple brain regions. Despite robust elevation in both mRNA and protein in multiple brain regions, plasma BDNF was unchanged and cerebrospinal fluid (CSF) BDNF levels remained undetectable. Primary neurons were then treated with KA. BDNF was similarly elevated within neurons, but was undetectable in neuronal media. Thus, while deficits in BDNF signaling have been implicated in a number of diseases, these data suggest that extracellular concentrations of BDNF may not be a facile biomarker for changes in neurons.
成年大鼠被急性给予外周性红藻氨酸(KA)处理,在多个脑区随时间推移追踪脑源性神经营养因子(BDNF)mRNA 和蛋白的变化。尽管在多个脑区的 mRNA 和蛋白都有明显升高,但血浆 BDNF 没有变化,脑脊液(CSF)BDNF 水平仍无法检测到。然后用 KA 处理原代神经元。神经元内的 BDNF 也同样升高,但神经元培养基中仍无法检测到。因此,尽管 BDNF 信号传导缺陷与许多疾病有关,但这些数据表明,BDNF 的细胞外浓度可能不是神经元变化的简单生物标志物。